Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (32 quarters reported)
$189M in Q4 2018 → $111M now. Hover for any quarter.
As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Draftkings Inc | 90.9% | Unchanged | 5,319,866 | $101M |
| Roku Inc | 7.9% | Unchanged | 57,707 | $8.79M |
| Snap Inc | 1.2% | Unchanged | 245,559 | $1.33M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2026 · filed October 28, 2026
No position changes this quarter.
quarter ended June 30, 2026 · filed July 28, 2026
No position changes this quarter.
quarter ended March 31, 2026 · filed May 01, 2026
No position changes this quarter.
quarter ended December 31, 2025 · filed January 29, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IA Integral Ad Science Hldng Co | Exited | −22,722,770 | −$231M | — |
quarter ended September 30, 2025 · filed October 30, 2025
No position changes this quarter.
quarter ended June 30, 2025 · filed July 25, 2025
No position changes this quarter.
quarter ended March 31, 2025 · filed May 08, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Draftkings Inc | Trimmed | −574,543 | −$19.1M | 48.3% |
quarter ended December 31, 2024 · filed February 11, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Larimar Therapeutics Inc | Exited | −112,184 | −$735K | — |
Loading...
